Clinical trials
Phase 2 Peripheral Arterial Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 9 |
| Terminated | 7 |
| Recruiting | 4 |
| Withdrawn | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Northwestern University | 4 |
| AnGes USA, Inc. | 2 |
| Celularity Incorporated | 2 |
| Duke University | 2 |
| Emory University | 2 |
| Flanders Medical Research Program | 2 |
| Novartis Pharmaceuticals | 2 |
| University of California, San Francisco | 2 |
| AMAG Pharmaceuticals, Inc. | 1 |
| Angiogenix | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Arterial Disease | 68 |
| Intermittent Claudication | 21 |
| Peripheral Vascular Diseases | 12 |
| Chronic Limb-Threatening Ischemia | 7 |
| Vascular Diseases | 7 |
| Arterial Occlusive Diseases | 5 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Mobility Limitation | 3 |
Trials
Showing 76 to 68 of 68. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.